What Are The Factors That Nurses Consider In Purchasing Nursing Scrubs From Rutherford
Among the key elements of their wardrobe, nursing...
Pharmaceutical Processing Equipment Market Worth $12.85 Billion by 2029
Meticulous Research® - the leading global market research company, published a research report titled, ‘Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills]) - Global Forecast to 2029’.Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5296?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=06-02-2024
According to this latest publication from Meticulous Research®, the global pharmaceutical processing equipment market is expected to grow at a CAGR of 4.2% to reach $12.85 billion by 2029. The pharmaceutical processing equipment market is driven by emerging technology trends in pharmaceutical manufacturing, rising approvals of orphan drugs, and the growing adoption of flexible technologies in pharmaceutical manufacturing. The expanding clinical pipeline of the novel therapies and emerging pharmaceutical manufacturing hotspots in emerging countries are offering opportunities for the growth of the Pharmaceutical Processing Equipment Market.
Pharmaceutical Processing Equipment Market: Future Outlook
The global pharmaceutical processing equipment market is segmented by mode of delivery (oral [oral solid dosages {blending equipment, fluidized bed machine, milling equipment, compression/press equipment, capsule making equipment, capsule filling equipment, and other processing equipment}, oral liquid dosages {sugar charging/transfer systems, preparation vessels, melting vessels, and storage tanks, stirrers and homogenizers, filtration units, and other processing equipment}], parenterals [mixing equipment, preparation tank, and other containers, process systems (SVP, LVP), filtration units, sterilization tunnels, clean-in-place (CIP) and steam-in-place (SIP) system, aseptic inspection systems, and other processing equipment], topicals [planetary and homogenizer mixer, preparation vessels, reactors, and storage tanks, colloid mills, agitator–stirrer, and other processing equipment]), and geography.
Based on the mode of delivery, the market is segmented into oral, parenteral, topical, and other formulations. In 2022, the oral formulations segment is estimated to account for the largest market share of the pharmaceutical processing equipment market. The oral formulations segment is further bifurcated into oral solid and liquid dosages. The oral solid dosages segment is projected to emerge as the fastest-growing segment during the forecast period. Emerging pharmaceutical therapies are not likely to substitute oral dose pharmaceutical products anytime soon. The expansion of oral solid dosage forms has continued, owing to the new solid dose formats and improved efficiency. Moreover, the largest proportion of the oral solid dosages segment, among the recently approved drugs by the U.S. FDA, also contributes to the market growth.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5296?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=06-02-2024
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Switzerland, Italy, Germany, U.K., France, Ireland, Spain, Denmark, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. North America is estimated to command the largest market share of the global pharmaceutical processing equipment market in 2022, followed by Europe and Asia-Pacific. The U.S. is estimated to be the largest market in 2022. Reshoring of pharmaceutical manufacturing to ensure the uninterrupted supply of pharmaceuticals, a large number of regulatory approvals for pharmaceuticals by the U.S. FDA, and high investment by pharmaceutical companies in the R&D are the key factors attributing to the largest revenue share. However, the Asia-Pacific region is projected to grow at the fastest CAGR during the forecast period.
The key players operating in the global pharmaceutical processing equipment market are ACG (India), Cadmach Machinery Company Private Limited (India), GEA GROUP (Germany), Sainty Co. (China), Syntegon Technology GmbH (Germany), Freund Corporation (Japan), ACIC Pharmaceuticals Inc. (Canada), Bausch+Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG (Germany), Fette Compacting GmbH (Germany), IDEX Corporation (U.S.), Kevin Process Technologies Private Limited (India), KIKUSUI SEISAKUSHO LTD. (Japan), KORSCH AG (Germany), MAQUINARIA INDUSTRIAL DARA, SL (Spain), and Marchesini Group S.p.A. (Italy).
Quick Buy: https://www.meticulousresearch.com/Checkout/23054852?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=06-02-2024
Key questions answered in the report-
• Which are the high-growth market segments in terms of mode of delivery and regions/countries?
• What was the historical market for pharmaceutical processing equipment across the globe?
• What are the market forecasts and estimates for 2022–2029?
• What are the major drivers, restraints, challenges, opportunities, and trends in the global pharmaceutical processing equipment market?
• Who are the major players in the global pharmaceutical processing equipment market?
• How is the competitive landscape, and who are the market leaders in the pharmaceutical processing equipment market?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post